Document is current
Any future updates will be listed below
-
Authors
Berbers, Roos-Marijn
Paganelli, Fernanda L.
van Montfrans, Joris M.
Ellerbroek, Pauline M.
Viveen, Marco C.
Rogers, Malbert R. C.
Salomons, Moniek
Schuurmans, Jaap
van Stigt Thans, Martine
Vanmaris, Remi M. M.
Brosens, Lodewijk A. A.
van der Wal, Maria Marlot
Dalm, Virgil A. S. H.
van Hagen, P. Martin
van de Ven, Annick A. J. M.
Uh, Hae-Won
van Wijk, Femke
Willems, Rob J. L.
Leavis, Helen L.
-
Funding
Funding for this research was provided by:
Wilhelmina Children’s Hospital Fund
Stichting Zeldzame Ziekten Fonds
Infection and Immunity research stimulus grant
- License Information
-
More Information
Article History
Received: 5 November 2023
Accepted: 19 November 2024
First Online: 16 January 2025
Declarations
:
: Ethical approval for this study for all Dutch participants was received from the Medical Ethical Committee of the Erasmus MC University Medical Center in Rotterdam, the Netherlands (METC: 2013–026). Written informed consent was obtained from all patients and controls according to the Declaration of Helsinki.
: Not applicable.
: PH reports research grants and personal fees from Shire/Takeda and CSL Behring. VD reports research grants and consulting fees from Shire/Takeda, Griffols, ACtelion, Novartis and CSL Behring. JM reports personal fees from Shire/Takeda. AvdV reports personal fees from Lamepro B.V.. HL reports research grants from Shire/Takeda. All other authors report no potential conflict of interest.
